Authors:
Ben Sedrine, W
Devogelaer, JP
Kaufman, JM
Goemaere, S
Depresseux, G
Zegels, B
Deroisy, R
Reginster, JY
Citation: W. Ben Sedrine et al., Evaluation of the simple calculated osteoporosis risk estimation (SCORE) in a sample of white women from Belgium, BONE, 29(4), 2001, pp. 374-380
Authors:
Zegels, B
Eastell, R
Russell, RGG
Ethgen, D
Roumagnac, I
Collette, J
Reginster, JY
Citation: B. Zegels et al., Effect of high doses of oral risedronate (20 mg/day) on serum parathyroid hormone levels and urinary collagen cross-link excretion in postmenopausal women with spinal osteoporosis, BONE, 28(1), 2001, pp. 108-112
Authors:
Emery, P
Reginster, JY
Appelboom, T
Breedveld, FC
Edelmann, E
Kekow, J
Malaise, M
Mola, EM
Montecucco, C
Sanda, M
Sany, J
Scott, DL
Serni, U
Seydoux, G
Citation: P. Emery et al., WHO Collaborating Centre consensus meeting on anti-cytokine therapy in rheumatoid arthritis, RHEUMATOLOG, 40(6), 2001, pp. 699-702
Citation: W. Ben Sedrine et al., On conducting burden-of-osteoporosis studies: a review of the core concepts and practical issues. A study carried out under the auspices of a WHO Collaborating Center, RHEUMATOLOG, 40(1), 2001, pp. 7-14
Authors:
Vignon, E
Garnero, P
Delmas, P
Avouac, B
Bettica, P
Boers, M
Ehrich, E
MacKillop, N
Rovati, L
Serni, U
Spector, T
Reginster, JY
Citation: E. Vignon et al., Recommendations for the registration of drugs used in the treatment of osteoarthritis: an update on biochemical markers, OSTEO CART, 9(4), 2001, pp. 289-293
Authors:
Henrotin, Y
de Leval, X
Mathy-Hartet, M
Mouithys-Mickalad, A
Deby-Dupont, G
Dogne, JM
Delarge, J
Reginster, JY
Citation: Y. Henrotin et al., In vitro effects of aceclofenac and its metabolites on the production by chondrocytes of inflammatory mediators, INFLAMM RES, 50(8), 2001, pp. 391-399
Authors:
Valat, JP
Accardo, S
Reginster, JY
Wouters, M
Hettich, M
Lleu, PL
Citation: Jp. Valat et al., A comparison of the efficacy and tolerability of meloxicam and diclofenac in the treatment of patients with osteoarthritis of the lumbar spine, INFLAMM RES, 50, 2001, pp. S30-S34
Authors:
Reginster, JY
Zegels, B
Lejeune, E
Micheletti, MC
Taquet, AN
Albert, A
Citation: Jy. Reginster et al., Influence of daily calcium and vitamin D supplementation on parathyroid hormone secretion, GYNECOL END, 15(1), 2001, pp. 56-62
Citation: Jy. Reginster et al., Correct regimen of fluoride and calcium reduces the risk of vertebral fractures in postmenopausal osteoporosis, OSTEOPOR IN, 12(9), 2001, pp. 800-800
Authors:
Tellier, V
De Maeseneer, J
De Prins, L
Ben Sedrine, W
Gosset, C
Reginster, JY
Citation: V. Tellier et al., Intensive and prolonged health promotion strategy may increase awareness of osteoporosis among postmenopausal women, OSTEOPOR IN, 12(2), 2001, pp. 131-135
Authors:
Paul, I
Bilge, A
Bolly, F
Boland, J
Reginster, JY
Citation: I. Paul et al., Pilot study for the registration of acute myocardial infarction in the Liege area (Belgium), REV EPIDEM, 49(5), 2001, pp. 423-429
Citation: Jy. Reginster, Risedronate increases bone mineral density and reduces the vertebral fracture incidence in postmenopausal women, CLIN EXP RH, 19(2), 2001, pp. 121-122
Authors:
Appelboom, T
Schuermans, J
Verbruggen, G
Henrotin, Y
Reginster, JY
Citation: T. Appelboom et al., Symptoms modifying effect of avocado/soybean unsaponifiables (ASU) in kneeosteoarthritis - A double blind, prospective, placebo-controlled study, SC J RHEUM, 30(4), 2001, pp. 242-247
Authors:
Reginster, JY
Henrotin, Y
Christiansen, C
Gamwell-Henriksen, E
Bruyere, O
Collette, J
Christgau, S
Citation: Jy. Reginster et al., Bone resorption in post-menopausal women with normal and low BMD assessed with biochemical markers specific for telopeptide derived degradation products of collagen type I, CALCIF TIS, 69(3), 2001, pp. 130-137
Authors:
Alexandersen, P
Toussaint, A
Christiansen, C
Devogelaer, JP
Roux, C
Fechtenbaum, J
Gennari, C
Reginster, JY
Citation: P. Alexandersen et al., Ipriflavone in the treatment of postmenopausal osteoporosis - A randomizedcontrolled trial, J AM MED A, 285(11), 2001, pp. 1482-1488
Citation: Jy. Reginster et al., Secular increase in the incidence of hip fractures in Belgium between 1984and 1996: need for a concerted public health strategy, B WHO, 79(10), 2001, pp. 942-946
Authors:
McClung, MR
Geusens, P
Miller, PD
Zippel, H
Bensen, WG
Roux, C
Adami, S
Fogelman, I
Diamond, T
Eastell, R
Meunier, PJ
Reginster, JY
Wasnich, RD
Greenwald, M
Kaufman, J
Chestnut, CH
Citation: Mr. Mcclung et al., Effect of risedronate on the risk of hip fracture in elderly women, N ENG J MED, 344(5), 2001, pp. 333-340
Authors:
Neer, RM
Arnaud, CD
Zanchetta, JR
Prince, R
Gaich, GA
Reginster, JY
Hodsman, AB
Eriksen, EF
Ish-Shalom, S
Genant, HK
Wang, OH
Mitlak, BH
Citation: Rm. Neer et al., Effect of parathyroid hormone (1-34) on fractures and bone mineral densityin postmenopausal women with osteoporosis., N ENG J MED, 344(19), 2001, pp. 1434-1441